Objective International comparison of complete uterine rupture.
0.5-0.7) in women without previous CS. Prevalence in women with previous CS was negatively correlated with previous CS rate (q = À0.917) and positively correlated with TOLAC rate of the background population (q = 0.600). Uterine rupture resulted in peripartum hysterectomy in 87 of 864 women (10%, 95% CI 8-12%) and in a perinatal death in 116 of 874 infants (13.3%, 95% CI 11.2-15.7) whose mother had uterine rupture. Overall rate of neonatal asphyxia was 28% in neonates who survived.
Introduction
Complete uterine rupture is the disruption of the full thickness of the uterine wall, including myometrium and uterine serosa, during pregnancy or delivery. 1, 2 This obstetric complication is rare with prevalences between 2.4 and 3.0 per 10 000 deliveries, [3] [4] [5] but is associated with severe outcomes for both mother and child. An emergency intervention is needed to prevent perinatal asphyxia and death, while the mother may suffer from life-threatening haemorrhage and end up with peripartum hysterectomy.
An increasing prevalence of complete uterine rupture can be largely explained by an increase in trial of labour after caesarean section (TOLAC) ( Figure S1 ). [6] [7] [8] [9] In general, TOLAC has been appreciated as a way to reduce increasing caesarean section (CS) rates, since Edward Cragin's statement 'once a cesarean always a cesarean' 100 years ago (1916) . 10 Practice guidelines on TOLAC published by leading professional associations also recommend TOLAC as a clinically safe choice for the majority of women with one previous CS, to limit further increase of CS rates and maternal morbidity associated with multiple CSs.
11 -15 However, TOLAC has become the main risk factor for uterine rupture, especially in high-income countries, and fear of medical litigation is an important reason for obstetricians to be reluctant to offer TOLAC to their patients. 16 Population-based rates of TOLAC differ considerably between countries. [16] [17] [18] The International Network of Obstetric Survey Systems (INOSS) is a multinational collaboration of organisations conducting prospective population-based studies of serious disorders in pregnancy and childbirth. 19 Nine INOSS members have conducted population-based studies on uterine rupture, the first started in 2004 and the latest completed in 2014, using comparable definitions and data collection forms, enabling international comparison of prevalence, risk factors, management and outcome.
We aimed to assess the overall prevalence of complete uterine rupture in these nine countries, to compare prevalences between the different countries and to assess the correlation between prevalence of complete uterine rupture and the countries' CS and TOLAC rates. We hypothesise that rates of uterine rupture per country will be proportional to rates of previous CS per country and rates of TOLAC per country. Further, we aimed to describe overall maternal and perinatal outcome associated with complete uterine rupture.
Methods

Research design
This study is a descriptive multi-country population-based study. We merged individual data of women with complete uterine rupture collected prospectively in nine populationbased studies within INOSS: AuOSS (Austrian Obstetric Surveillance System) in Austria, B.OSS (Belgian Obstetric Surveillance System) in Belgium, EPIMOMS (EPIdemiologie de la MOrbidit e Maternelle S ev ere) in France, NOSS (Nordic Obstetric Surveillance System) with data from Denmark, Finland and Sweden, GerOSS (German Obstetric Surveillance System) in Lower Saxony, Germany; LEMMoN (Landelijke studie naar Etnische determinanten van Maternale Morbiditeit, now called NethOSS, Netherlands Obstetric Surveillance System) in the Netherlands and UKOSS (United Kingdom Obstetric Surveillance System) in the UK. All population-based studies were nationwide, except for GerOSS in Germany, which encompassed the region of Lower Saxony only, and EPIMOMS in France, which encompassed six regions (Alsace, Auvergne, Basse-Normandie,Île-de-France, Lorraine and Rhône-Alpes) covering one-fifth of national births. Women were actively involved designing, managing and interpreting data for individual component studies.
Definitions
For the purpose of this study we included only cases that correspond to an objective anatomical definition of complete uterine rupture, namely complete disruption of the uterine muscle and the uterine serosa, irrespective of the condition of the fetal membranes. The definitions of uterine rupture used by the different participating countries are listed in the Supplementary material (Table S1 ). There were two countries where a compromise was needed to enable inclusion of their registered cases. The Netherlands used a clinical definition rather than an anatomical definition, namely cases of uterine rupture where clinical symptoms led to an emergency CS or laparotomy; we agreed to include all registered cases, aware that some may have been incomplete ruptures. France registered cases of complete uterine rupture only if associated with severe acute maternal morbidity. This comprises only cases of complete uterine rupture with severe obstetric haemorrhage and cases where the women underwent peripartum hysterectomy or laparotomy for complete uterine rupture after vaginal birth. 20 Uterine ruptures occurring in labour after a previous CS were used as a proxy for uterine ruptures in women undergoing TOLAC.
Short-term maternal outcomes were peripartum hysterectomy and maternal mortality. The severe adverse neonatal outcome was defined as neonatal asphyxia and/or perinatal mortality. Neonatal asphyxia was defined as umbilical artery pH ≤ 7.0 and/or Apgar score <7 at 5 minutes and/or need for resuscitation including endotracheal ventilation and/or neurological manifestations (seizures). 21 
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Stillbirth was defined as intrauterine fetal death after 24 completed weeks of gestation. Perinatal mortality was defined as stillbirths and early neonatal deaths (up to 7 days of life). Stillbirths that occurred before uterine rupture were not included in perinatal mortality rates.
Data collection, processing and cleaning
Data-collection in each population-based study was accomplished according to prospective case-collection schemes, similar to the UKOSS methodology. 22 Call for cases took place on a bi-, tri-or (mostly) monthly basis by sending a report card by email or fax to a nominated clinician in each maternity unit in the country or region under surveillance, asking them to report all cases of uterine rupture that occurred in the past month and to complete the report card also when there was no case to report. Data-collection differed in France, Finland and Denmark: in France clinicians were contacted by monthly calls or emails, in Denmark and Finland clinicians reported their cases spontaneously; in addition, registers (Medical Birth Register, Hospital Discharge Register and/or delivery logbooks) were used to identify missing cases, which were added to the study after they were found to be true cases. For every reported case clinicians, research midwives or scientific collaborators completed data collection forms (paper or electronic). These sought confirmation of the appropriate case definition and additional information on risk factors, management and outcomes. All countries used paper-based or web-based data-collection forms (www.geross.de, www. b-oss.be, https://www.npeu.ox.ac.uk/inoss/organisations/ noss). Each population-based study group processed and cleaned their data. National data were published in peerreviewed journals and/or organisational reports before the start of this international study. 17, 18, [23] [24] [25] De-identified data were transferred to the principal investigator of this study, according to applicable data transfer policies, which differed by country.
Registered variables
To facilitate matching of nine different databases, 37 variables were selected based on their presence in data collection forms of all nine countries and their significance for analysis. The set of 37 variables and codebook are listed in the (Table S2 ). Variables comprised details about previous obstetric history, previous medical history, current pregnancy and labour, uterine rupture and its management, and maternal and perinatal outcome. Proportion of women who had previously delivered by CS (%), CS rates, TOLAC rates and vaginal birth after caesarean section (VBAC) rates in each country were derived from the most recent available perinatal data or the perinatal data closest to the study period or from previous population-based studies. 17, 18, [24] [25] [26] [27] [28] [29] [30] [31] [32] At the time of analysis, a core outcome set for severe maternal morbidity in general, or uterine rupture specifically, had notbeen developed. 33 
Statistical analysis
Data were analysed using statistical software package IBM SPSS Statistics for Windows, Version 22.0. 34 For most research objectives, variables were expressed as relative frequencies and analysis was confined to descriptive statistics. Prevalences were calculated with 95% CI using the Wilson score method. 35 Lower limits of gestational age appeared to differ within and between countries in uterine rupture studies as well as in civil birth registers (Table S3) . In an attempt to adjust for this discrepancy, prevalences were re-calculated using as numerator cases of complete uterine rupture ≥24 weeks of gestation and as denominator the estimated number of deliveries in the background population ≥24 weeks of gestation, if information was available. These adjusted prevalences differed little (maximum 0.67 per 10 000 deliveries) from the overall prevalences (Table S4) .
Estimated numbers of deliveries with and without previous CS ( Figure 1 ) were calculated based on estimates of the proportion of women previously delivered by CS (%) in each country. Correlations between prevalence of complete uterine rupture and previous CS, CS, TOLAC and VBAC rates per country were calculated using nonparametric Spearman Rank Order correlations (q). P-values of <0.05 were considered statistically significant.
Estimated numbers per 10 000 deliveries per country ( Figure 2 ) were calculated based on the numbers in Figure 1 and Table S5 . We calculated estimated numbers of women with previous CS per 10 000 deliveries, and, similarly, estimated numbers of women with previous CS who underwent TOLAC, who succeeded in VBAC, who underwent emergency CS following TOLAC and who underwent elective repeat CS per 10 000 deliveries ( Figure S1 ).
Perinatal mortality and neonatal asphyxia rates were calculated using as denominator all neonates of women with complete uterine rupture, with exclusion of immature neonates (<24 weeks of gestation, n = 24), stillbirths before uterine rupture (n = 8), neonates with major congenital anomalies (n = 7) and neonates with unknown outcome missing gestational age (n = 4), data missing on stillbirth versus live birth (n = 84), liveborn neonates with data missing to assess asphyxia (n = 64), liveborn neonates suffering from asphyxia but missing data on neonatal mortality (n = 5).
Results
Prevalence of complete uterine rupture
This multi-country study comprised 864 cases of complete uterine rupture in 2 625 017 deliveries from nine countries with an overall prevalence of 3.3 (95% CI 3.1-3.5) per 10 000 deliveries (Table S6) . Finland reported the highest prevalence of 7.8 (95% CI 6.5-9.4) per 10 000 deliveries and Austria the lowest prevalence of 1.6 (95% CI 1.1-2.2) per 10 000 deliveries.
Estimated prevalence of complete uterine rupture in women with previous CS was 22 (95% CI 21-24) per 10 000 deliveries compared with 0.6 (95% CI 0. (Table S7) .
Prevalence of uterine rupture in relation to TOLAC rates
Associations between estimated prevalence of complete uterine rupture and rates of CS, previous CS, TOLAC and VBAC in countries are displayed in Figure 1 . We noted a strong negative correlation between previous CS rates and prevalence of uterine rupture (q = -0.854 for total prevalence and q = -0.917 for prevalence in women with previous CS). Likewise, we identified a strong positive correlation between TOLAC rates and prevalence of uterine rupture (q = 0.611 for total prevalence and q = 0.600 for prevalence in women with previous CS) (Figures S2, S3 and S4). Additionally, VBAC rates were positively correlated with the proportion of TOLAC in the countries (q = 0.740).
Based on the numbers in Figure 1 and Table S5 we estimated the number of women with previous CS and, similarly, the number of women with previous CS who underwent TOLAC, who achieved VBAC, who underwent emergency CS following TOLAC and who underwent elective repeat caesarean section per 10 000 deliveries (Figure 2 ; Figure S1 ).
Maternal outcome
Management and maternal outcome of women with complete uterine rupture are reported in Table S8 . The proportionally high number of women who had laparotomy following vaginal delivery, who underwent hysterectomy or received more than 4 units of packed cells in the French study is related to the different inclusion criteria, where severe acute maternal morbidity was a prerequisite for inclusion. 20 All countries verified maternal deaths and only two were reported, both in the study from the UK, resulting in an overall case fatality rate of 0.23% (95% CI 0.06-0.84%).
Forty of 627 women with uterine rupture associated with TOLAC underwent hysterectomy (6.4%, 95% CI 4.7-8.6), resulting in a rupture-related hysterectomy rate of 2.2 (95% CI 1.6-3.0) per 10 000 women undergoing TOLAC, taking into account the overall uterine rupture rate of 35 (95% CI 32-37) per 10 000 TOLACs.
Perinatal outcome
We analysed maternal and perinatal outcome resulting from complete uterine rupture in 864 women. The study involved eight twins and one triplet pregnancy, resulting in 874 fetuses or newborns. Characteristics of women with complete uterine rupture and their fetus/neonates are shown in the (Table S9) .
The majority of uterine ruptures occurred beyond 37 weeks of gestation (722 women with 727 neonates, 83.2%), of whom 161 neonates (18%) were beyond 41 weeks and 56 (6%) beyond 42 weeks. Perinatal outcome in all cases of complete uterine rupture is shown in Figure 3A . Perinatal outcome of a subgroup of women who underwent TOLAC, is shown in Figure 3B .
The rupture-related perinatal mortality rate in this multi-country study was 116 (95% CI 95-141) per 1000 neonates; neonatal asphyxia was observed in 280 (95% CI 248-315) per 1000 neonates who survived (Table S10) , resulting in 39.6% of neonates with severe outcome.
In women who underwent TOLAC, perinatal mortality rate was 90 (95% CI 68-117) per 1000 neonates and the rate of neonatal asphyxia was 263 (95% CI 226-304) per 1000 surviving neonates, resulting in 35.3% of neonates with severe outcome. Perinatal mortality rate ranged from 0.8 to 13.2 per 10 000 TOLACs between countries (Table 1) .
Discussion
Main findings
There is a wide variation in prevalence of complete uterine rupture between countries (1.6 to 7.8 per 10 000 deliveries), which also exists in the rate of uterine rupture per TOLAC (16 to 80 per 10 000 deliveries), proportional to TOLAC uptake rates per country and inversely proportional to CS rates per country.
Sixty percent of neonates of women with complete uterine rupture overall and 65% of neonates with TOLAC did not have severe outcome.
Strengths and limitations
A strength of this study is its international design: in the INOSS collaboration we managed to collect a large number of cases of validated complete uterine ruptures from nine countries or regions by accumulation of small numbers registered according to analogous methods. Moreover, the multi-national design with participation of nine European countries facilitated comparison between high-income countries with varying CS and TOLAC rates. Ascertainment-bias caused by the inclusion of two studies that used different definitions of uterine rupture, however, is an important limitation. Systematic over-reporting of cases in the Netherlands and restriction of inclusions to cases associated with severe acute maternal morbidity in France will certainly affect the comparison between cases, and conclusions should therefore be interpreted with caution. Another limitation is lack of information on intended mode of delivery. Thus, women who presented in spontaneous labour despite having planned elective repeat caesarean section ( Figure S1 ) were classified by actual mode of delivery, and the number of women undergoing TOLAC may be overestimated. Also, TOLAC rates of the background populations were derived from the countries' perinatal data using the same approximation in Austria, Belgium, France, Germany, Denmark, Finland and Sweden.
To overcome these limitations of varying definitions of completeness of a uterine rupture, INOSS has developed international consensus definitions for severe maternal morbidities including complete uterine rupture using a Delphi procedure, and developed a set of core outcome measures for future studies. 2 
Interpretation
Prevalence of uterine rupture This is the largest prospective population-based report in high-income countries with clinical verification of uterine rupture, i.e. not based on International Classification of Diseases codes. Prevalences of uterine rupture in the literature differ greatly, according to whether studies are register-based, population-or facility-based, occurred in highincome or low-and middle-income countries, depending on the definition used (e.g. complete, incomplete, symptomatic rupture, dehiscence), on gestational age cut-off (e.g. including first and second trimester versus only term pregnancies) and on data sources. Register-based surveys that rely only on International Classification of Diseases codes are known to overestimate (false positives), while they miss a substantial number of true uterine ruptures that are under-reported (false negatives). 36, 37 Other population-based reports on overall rates of uterine rupture are scarce. The World Health Organization's systematic review in 2005 reported a median prevalence of 2.5 (range 1.6-7.0) per 10 000 deliveries based on five studies in highincome countries from 1995 to 1998. 3 In a large Norwegian register-based study validated by review of medical records, the overall prevalence over 40 years was 1.3 (95% CI 1.2-1.5), increasing from 1.0 (95% CI 0.6-1.3) to 3.0 (95% CI 2.4-3.6) per 10 000 deliveries from the first to the last decade (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . 4 A large population-based study in the USA reported a prevalence of 2.4 (95% CI 2.3-2.5) per 10 000 deliveries based on vital statistics data from 2011 to 2012. 5 We further explored the literature for population-based reports of uterine rupture in women with previous CS in high-income countries. Compared with three relatively large sources (Al-Zirqi et al., 4 Guise et al., 38 and Landon et al. 7 ) reporting prevalences between 30 (95% CI 24-36) and 36 (95% CI 30-43) per 10 000 deliveries, 4,7,9 the prevalence in our study is lower, with a notably wide range between countries. 
Utilisation patterns of TOLAC
The range in prevalence in women with previous CS appears to be, among others, a consequence of the range in TOLAC rates between countries (from 47% to 72%). Countries with lower overall CS rates, that are more restrictive in performing CSs and consequently have lower numbers of women with previous CS, appear more tolerant in their selection of candidates for TOLAC, and more successful in achieving VBAC, at the expense of a slightly higher number of uterine ruptureS per TOLAC. In contrast, countries with higher overall CS rates, hence more permissive in performing CSs and consequently having a higher number of women with previous CS, are more selective in allowing TOLAC, and less successful in achieving VBAC, in favour of a slightly lower number of uterine rupture per TOLAC. Practice guidelines on TOLAC published by four large professional associations [11] [12] [13] [14] differ only modestly on a few matters, e.g. availability of appropriate personnel to perform emergency CS. Guidelines recommend that the final decision to undergo TOLAC should be made through shared decision-making by the woman in consultation with her obstetrician. 11, 12 It stands to reason, supported by growing evidence, that obstetricians can easily influence women's decisions. 16, 39 Obstetricians, in turn, will be influenced by factors related to the healthcare system, institutional and organisational factors, and litigation. 16 Healthcare providers can contribute to lower TOLAC rates by providing higher reimbursement for CSs compared with vaginal deliveries. Yee et al. identified a more than two-fold increase in the likelihood of attempting TOLAC, with a similar increase in VBAC, in a night float call system (schedule in which the provider has clinical responsibilities for labouring women only for a day or night shift) compared with a traditional call system. 39 Obstetricians working in institutions with obstetric, paediatric, anaesthetic and operating room staff immediately available might be more likely to offer TOLAC. According to the National Institutes of Health, the American Congress of Obstetricians and Gynecologists recommendations on staff availability caused a number of US hospitals to stop offering TOLAC and therefore restricted women's access to TOLAC. This international comparison study suggests that an important trade-off of a more liberal use of TOLAC is that while CS rates may decrease, the uterine rupture risk per TOLAC my increase modestly.
Maternal outcome
The rate of hysterectomy related to uterine rupture in our study is 10% (n = 87). A Norwegian population-based study over 40 years reported a rupture-related hysterectomy rate of 11.4% in the last decade (2000-2008) with a major decrease from 35.5% in the first decade (1967) (1968) (1969) (1970) (1971) (1972) (1973) (1974) (1975) (1976) (1977) . 4 Overall hysterectomy rate in women with previous CS undergoing TOLAC was 0.17% in a systematic review by Guise et al. 38 and 0.2% in a prospective cohort study by Landon et al. 7 Hence, we can state that the rupture-related hysterectomy rate in women undergoing TOLAC is extremely low (2.2 per 10 000 women in this study).
This study included two maternal deaths, resulting in a case fatality rate of 0.23% (95% CI 0.06-0.84%). In comparison, the World Health Organization's reported a case fatality rate between 1% and 13% in low-and middleincome countries. 3 The overall rate of maternal death in women with previous CS undergoing TOLAC in the systematic review of Guise et al. was 0.004%, 16, 38 whereas Landon et al. reported a rate of 0.02%. 7 
Perinatal outcome
The rupture-related rate of perinatal death in women undergoing TOLAC is extremely low: 3.2 per 10 000 TOLACs in our study and ranging from 1.1 to 4.7 per 10 000 TOLACs in the literature. 7, 40, 41 In a systematic review based on five cohort studies, Guise et al. found a pooled rupture-related rate of perinatal deaths of 13 (range 6-29) per 10 000 TOLACs. 38 The lowest perinatal mortality rate in France (0.8 per 10 000 TOLACs) is probably related to the different definition of uterine rupture limited to cases associated with severe acute maternal morbidity, the highest rate in Sweden (13.2 per 10 000 TOLACs) probably due to the large number of missing data of neonatal outcome in the Swedish study. Perinatal mortality rate in the other countries ranged between 1.2 and 4.1 per 10 000 TOLACs.
The overall rate of neonatal asphyxia associated with complete uterine rupture in our study was 28% in the neonates who survived and 26% in the subgroup of babies born after uterine ruptures associated with TOLAC, resulting in a rate of 9.1 (95% CI 8.4-9.7) per 10 000 TOLACs. However, because of missing data, use of a proxy for asphyxia, and lack of information on long-term effects in this study, it is inappropriate to make firm conclusions on perinatal morbidity related to TOLAC. Rupture-related perinatal asphyxia reported in the literature ranges from 4.6 per 10 000 TOLACs (based on HIE) 7, 42 to 15 and 40 per 10 000 TOLACS (based on umbilical artery pH < 7.0). 40, 43 Future research Obviously, outcome of complete uterine rupture is strongly related to the interval between the time of diagnosis and time of delivery of the neonate. Many authors refer to two observational studies of Leung et al. (n = 116 uterine ruptures) and Holmgren et al. (n = 36 uterine ruptures), who both reported a diagnosis-to-delivery interval of <18 minutes associated with umbilical cord pH levels >7.0.
44,45
Holmgren et al. further reported that all neonates delivered within 30 minutes had uncomplicated long-term outcome. In this respect, the American Congress of Obstetricians and Gynecologists practice bulletin's recommendation that TOLAC should be undertaken in facilities with staff immediately available to perform emergency CS, seems highly appropriate. 11 Further studies are needed to increase evidence of the impact of organisational factors on outcome of complete uterine rupture related to TOLAC. These studies should include well-defined outcome parameters (stillbirth, early and late neonatal mortality, umbilical artery pH, long-term morbidity), comparable groups (adjusted for gestational age, previous CS and TOLAC) and take into account in-house availability of staff to perform immediate CS, number of annual births per hospital and diagnosisto-decision-to-delivery interval.
Benchmarking population-based TOLAC rates against uterine rupture rates reveals that countries with high TOLAC rates pay a higher price in uterine ruptures per TOLAC, whereas countries with low TOLAC rates pay a higher price of repeat CSs per VBAC. To evaluate whether one is preferable above the other, associated morbidity and mortality must be taken into consideration. Long-term maternal morbidities associated with CS and multiple scars to the uterus, such as abnormally invasive placenta and peripartum hysterectomy, are equally relevant in determining optimal TOLAC rates. The NOSS study group, among others, demonstrated an increasing prevalence of abnormally invasive placenta with increasing number of previous CSs. 46 Considering TOLAC inevitably involves a trade-off between the rate of abnormally invasive placenta (1/363 in women with two previous CS in the NOSS) and the rate of uterine rupture (1/294 in women undertaking TOLAC in our study).
Once again, the results of this study emphasise that population-based rates of unnecessary primary caesarean sections should be kept as low as possible. 47 
Conclusion
We observed a higher prevalence of complete uterine rupture per TOLAC in countries with relatively low previous CS and high TOLAC rates.
Rupture-related rates of hysterectomy and perinatal mortality in women undergoing TOLAC are extremely low (2.2 and 3.2 per 10 000 TOLACs, respectively). Future studies are needed to improve prediction of complete uterine rupture and management of TOLAC to further decrease the 10% rate of hysterectomy and perinatal death associated with complete uterine rupture.
Disclosure of interests
None declared. Completed disclosure of interests form available to view online as supporting information.
Contribution to authorship
GV, KB, SB, LC, CD, MG, MK, JLR, PL, WO, JV, JZ and KR contributed in the conception of the study and provided data. GV and KR designed the study. GV coordinated data collection, processing and analysis. GV, KB, SB, LC, CD, MG, MK, JLR, PL, WO, JV, JZ and KR contributed in the interpretation of the data. GV drafted the article. GV, KB, SB, LCCD, MG, MK, JVL, PL, WO, JV, JZ and KR critically revised the article and approved the final version. GV, KB, SB, LC, CD, MG, MK, JLR, PL, WO, JV, JZ and KR agree to be accountable for all aspects of the work. Authors are listed in alphabetical order between the first and last author.
Details of ethics approval
Each population-based study was approved individually by their Ethics Committees (Table S11 ). The international study was approved by the Medical Ethics Committee of the Ghent University Hospital in Belgium (23 March 2016; EC UZG 2016/0453).
Funding
There was no funding for this study. Sweden: We would like to acknowledge all the NOSS reporting clinicians who contributed data to the study and and Karin Gottvall and Karin K€ allen at the Medical Birth Registry.
United Kingdom: We would like to acknowledge all the UKOSS reporting clinicians who contributed data to the study.
Supporting Information
Additional supporting information may be found online in the Supporting Information section at the end of the article: Figure S1 . Possible pathways in parturient women with previous CS. Figure S2 . Correlation between uterine rupture rates in women with previous CS and CS rates in the background population (q = À0.917). Figure S3 . Correlation between uterine rupture rates in women with previous CS and TOLAC rates in the background population (q = 0.600) Figure S4 . Correlation between TOLAC rates in the background population and previous CS rates in the background population (q = À0.633). Table S1 . The definitions of uterine rupture used by the different participating countries. Table S2 . The set of 37 variables and codebook. Table S3 . Registration criteria of live births and stillbirths in the Civil Birth Register and/or Perinatal Register per country. Table S4 . Estimated prevalence (and 95% CI) of complete uterine rupture per 10 000 deliveries in the different participating countries: overall and ≥24 weeks. Table S5 . Estimated prevalence per 10 000 deliveries of uterine rupture in women with previous CS and labouring, compared with CS rate, TOLAC rate and VBAC rate in the different participating countries. Table S6 . Estimated prevalence (and 95% CI) of complete uterine rupture per 10 000 deliveries. Table S7 . Estimated prevalence (and 95% CI) per 10 000 deliveries of complete uterine rupture in women with and without previous CS. Table S8 . Management and maternal outcome in women with complete uterine rupture. Table S9 . Characteristics of women with complete uterine rupture and their fetus/neonates, per country. 
